Invention Grant
US09399619B2 Sulfamoylbenzamide derivatives as antiviral agents against HBV infection
有权
磺酰基苯甲酰胺衍生物作为抗HBV病毒感染的抗病毒药物
- Patent Title: Sulfamoylbenzamide derivatives as antiviral agents against HBV infection
- Patent Title (中): 磺酰基苯甲酰胺衍生物作为抗HBV病毒感染的抗病毒药物
-
Application No.: US14130140Application Date: 2012-06-29
-
Publication No.: US09399619B2Publication Date: 2016-07-26
- Inventor: Ju-Tao Guo , Xiaodong Xu , Timothy M. Block
- Applicant: Ju-Tao Guo , Xiaodong Xu , Timothy M. Block
- Applicant Address: US PA Doylestown US PA Philadelphia
- Assignee: Baruch S. Blumberg Institute,Drexel University
- Current Assignee: Baruch S. Blumberg Institute,Drexel University
- Current Assignee Address: US PA Doylestown US PA Philadelphia
- Agency: Saul Ewing LLP
- Agent Kathryn Doyle; Domingos J. Silva
- International Application: PCT/US2012/044775 WO 20120629
- International Announcement: WO2013/006394 WO 20130110
- Main IPC: A61K31/18
- IPC: A61K31/18 ; A61K31/34 ; A61K31/44 ; A61K31/445 ; A61K31/535 ; A61K31/54 ; C07C311/46 ; C07D281/16 ; C07D295/26 ; C07D213/40 ; C07D307/52 ; C07D307/68 ; C07D211/96 ; C07D223/04 ; A61K31/167 ; A61K31/55 ; A61K31/541 ; A61K31/5377 ; A61K31/341
Abstract:
Pharmaceutical compositions of the invention comprise sulfamoylbenzamide derivative useful as pregenomic RNA encapsidation inhibitors, useful for the treatment of Hepatitis B virus (HBV) infection.
Public/Granted literature
- US20140206666A1 SULFAMOYLBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION Public/Granted day:2014-07-24
Information query
